PL3402537T3 - Ilościowe obrazowanie pet ekspresji czynnika tkankowego z wykorzystaniem hamowanego czynnika vii aktywnego miejsca znakowanego 18f - Google Patents
Ilościowe obrazowanie pet ekspresji czynnika tkankowego z wykorzystaniem hamowanego czynnika vii aktywnego miejsca znakowanego 18fInfo
- Publication number
- PL3402537T3 PL3402537T3 PL17738231T PL17738231T PL3402537T3 PL 3402537 T3 PL3402537 T3 PL 3402537T3 PL 17738231 T PL17738231 T PL 17738231T PL 17738231 T PL17738231 T PL 17738231T PL 3402537 T3 PL3402537 T3 PL 3402537T3
- Authority
- PL
- Poland
- Prior art keywords
- active site
- pet imaging
- quantitative pet
- site inhibited
- factor vii
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/6408—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201670019 | 2016-01-15 | ||
| PCT/DK2017/050006 WO2017121436A1 (en) | 2016-01-15 | 2017-01-13 | Quantitative pet imaging of tissue factor expression using 18f-labled active site inhibited factor vii |
| EP17738231.4A EP3402537B1 (en) | 2016-01-15 | 2017-01-13 | Quantitative pet imaging of tissue factor expression using 18f-labelled active site inhibited factor vii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3402537T3 true PL3402537T3 (pl) | 2021-07-19 |
Family
ID=59310834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17738231T PL3402537T3 (pl) | 2016-01-15 | 2017-01-13 | Ilościowe obrazowanie pet ekspresji czynnika tkankowego z wykorzystaniem hamowanego czynnika vii aktywnego miejsca znakowanego 18f |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190015532A1 (pl) |
| EP (1) | EP3402537B1 (pl) |
| AU (1) | AU2017206445B2 (pl) |
| CA (1) | CA3010310C (pl) |
| DK (1) | DK3402537T3 (pl) |
| ES (1) | ES2856968T3 (pl) |
| PL (1) | PL3402537T3 (pl) |
| WO (1) | WO2017121436A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6701217B2 (ja) | 2014-11-25 | 2020-05-27 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 生物学的製剤の１８ｆ−放射性標識方法および組成物 |
| KR102632418B1 (ko) | 2014-11-25 | 2024-01-31 | 브리스톨-마이어스 스큅 컴퍼니 | 영상화를 위한 신규 pd-l1 결합 폴리펩티드 |
| CN109562195A (zh) | 2016-06-01 | 2019-04-02 | 百时美施贵宝公司 | 用pd-l1结合多肽进行pet成像 |
| WO2017210335A1 (en) * | 2016-06-01 | 2017-12-07 | Bristol-Myers Squibb Company | Imaging methods using 18f-radiolabeled biologics |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990003390A1 (en) | 1988-09-23 | 1990-04-05 | Corvas, Inc. | Peptidyl inhibitors of the initiation of coagulation |
| US5190919A (en) | 1989-11-13 | 1993-03-02 | Board Of Regents, The University Of Texas System | Antihemostatic factor vii peptides |
| US5788965A (en) | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
| WO1992015686A1 (en) | 1991-02-28 | 1992-09-17 | Zymogenetics, Inc. | Modified factor vii |
| WO1994027631A1 (en) | 1993-05-21 | 1994-12-08 | Zymogenetics, Inc. | Modified factor vii |
| US5833982A (en) | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
| CA2164422A1 (en) | 1993-06-18 | 1995-01-05 | Ross Wentworth Stephens | Factor vii-derived peptides |
| GB9425380D0 (en) | 1994-12-15 | 1995-02-15 | Nycomed Pharma As | Peptides |
| US6500934B1 (en) | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
| EP1198479B1 (en) | 1999-07-01 | 2008-06-18 | Yale University | Neovascular-targeted immunoconjugates |
| AU7270600A (en) | 1999-09-20 | 2001-04-24 | Novo Nordisk A/S | Bivalent inhibitor of fviia/tf/fxa complex |
| AU2001254624A1 (en) | 2000-05-03 | 2001-11-12 | Novo-Nordisk A/S | Human coagulation factor vii variants |
| EP1319067A2 (en) | 2000-09-13 | 2003-06-18 | Novo Nordisk A/S | Human coagulation factor vii variants |
| WO2004007557A2 (en) | 2002-07-12 | 2004-01-22 | Novo Nordisk A/S | Tf antagonist |
| JP2006516564A (ja) * | 2003-01-22 | 2006-07-06 | ノボ ノルディスク アクティーゼルスカブ | Ｔｆ結合薬剤及びそれらの使用 |
-
2017
- 2017-01-13 EP EP17738231.4A patent/EP3402537B1/en active Active
- 2017-01-13 AU AU2017206445A patent/AU2017206445B2/en not_active Ceased
- 2017-01-13 US US16/070,073 patent/US20190015532A1/en not_active Abandoned
- 2017-01-13 WO PCT/DK2017/050006 patent/WO2017121436A1/en not_active Ceased
- 2017-01-13 CA CA3010310A patent/CA3010310C/en active Active
- 2017-01-13 DK DK17738231.4T patent/DK3402537T3/da active
- 2017-01-13 PL PL17738231T patent/PL3402537T3/pl unknown
- 2017-01-13 ES ES17738231T patent/ES2856968T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK3402537T3 (da) | 2021-03-29 |
| WO2017121436A1 (en) | 2017-07-20 |
| CA3010310A1 (en) | 2017-07-20 |
| CA3010310C (en) | 2022-11-22 |
| EP3402537A1 (en) | 2018-11-21 |
| ES2856968T3 (es) | 2021-09-28 |
| AU2017206445A1 (en) | 2018-07-26 |
| AU2017206445B2 (en) | 2019-07-18 |
| EP3402537A4 (en) | 2019-08-28 |
| US20190015532A1 (en) | 2019-01-17 |
| EP3402537B1 (en) | 2021-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280899A (en) | Heterocyclic compounds for cancer imaging and treatment and methods for their use | |
| GB2530448B (en) | Preparation method for implantable medical biological materials of animal origin | |
| PT3481285T (pt) | Implantes utilizando ondas ultrassónicas para estimular tecido | |
| EP3534772A4 (en) | ORBITAL FABRIC SPREADER | |
| DK3191020T3 (da) | Medicinsk/kirurgisk implantat | |
| PT3212233T (pt) | Terapia combinada para o tratamento de doenças | |
| DK3107487T3 (da) | Kropsimplantater til blødt væv | |
| EP3122281A4 (en) | Quantitative three-dimensional imaging and printing of surgical implants | |
| BR112017009342A2 (pt) | formulações e tratamentos para cuidado com a pele | |
| CL2016002300A1 (es) | Combinaciones de principios activos insecticidas y nematocidas | |
| IL251246A0 (en) | Therapeutically active compounds and methods of use | |
| ZA201703346B (en) | Conjugated bisphosphonates for the diagnosis and therapy of bone diseases | |
| IL253796A0 (en) | Therapeutically active compounds and methods of use | |
| PL3467111T3 (pl) | IncRNA do terapii i diagnozowania przerostu serca | |
| HUE059303T2 (hu) | Acetilkolin-észteráz-gátlók bõrbetegségek kezelésére | |
| IL250990A0 (en) | Materials for human care | |
| EP3212170A4 (en) | Implantable medical devices for extended release of therapeutic agents | |
| HUE051296T2 (hu) | Benzoxazinon-származékok bõrbetegségek kezelésére | |
| IL254706B (en) | A medical system for penetrating the anatomical structure of patients | |
| HUE064813T2 (hu) | NK-3 receptor antagonisták testzsírfelesleg terápiás vagy kozmetikai kezelésére | |
| IL251349A0 (en) | Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages | |
| LT3168214T (lt) | Pakeisti 2-tiokso-imidazolidin-4-onai ir jų spiro analogai, aktyvi priešvėžinė sudedamoji dalis, farmacinė kompozicija, medicininis paruošimas, prostatos vėžio gydymo būdas | |
| PT3025734T (pt) | ¿método para desinfeção e esterilização de material de tecido animal | |
| PL3402537T3 (pl) | Ilościowe obrazowanie pet ekspresji czynnika tkankowego z wykorzystaniem hamowanego czynnika vii aktywnego miejsca znakowanego 18f | |
| GB201611413D0 (en) | Method of skin care |